Brand / product

Moxilab

Moxifloxacin · 0.5%

₨ Official source-observed price PKR 304.69 3ml

PKR 101.56 / mL

✓ Official DRAP price source observed · Source checked 2026-10-09

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 101.56/ mL

Price positionNear medianvs like-for-like peer median

Peer comparators1current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Moxifloxacin
Therapeutic area: Anti-infectives
Drug class: Fluoroquinolone antibacterials
ATC: J01MA
Strength: 0.5%
Dosage form: Ophthalmic drops
Pack: 3ml
Registration no.: 101028
Price record verified: 2026-08-08
Latest DRAP source check: 2026-10-09 03:22

Manufacturer

Medimarker's Laboratories

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Summary

About Moxilab 0.5% ophthalmic drops

Moxilab 0.5% ophthalmic drops contains Moxifloxacin 0.5%. It is registered with DRAP by Medimarker's Laboratories (registration no. 101028). Its official price is PKR 304.69 for a pack of 3ml. This price has applied since 27 July 2026. It is sold in 2 pack sizes: 3ml and 5ml. Moxilab is also available as 400 mg IV infusion and 400 mg tablet. No other brand of Moxifloxacin 0.5% in this form is listed in Pakistan.

Pack sizes

Moxilab 0.5% pack sizes and prices

Pack	Official price	Per tablet
3ml (this page)	PKR 304.69	—
5ml	PKR 507.81	—

Same brand

Other strengths of Moxilab

Moxilab 400 mgIV infusion · 250ml vial · PKR 1,846.59 Moxilab 400 mgTablet · 5's · PKR 981.04

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (3ml). Current price PKR 304.69, effective 27 Jul 2026.

Cite this price history

MedInfoBase. Moxilab 0.5%, 3ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/moxilab-0-5-101028-3ml-medimarkers-laboratories-13405/ (accessed 9 October 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 304.69	2026-07-27	2026-08-08	DRAP PharmaPrice Index	Current

Same generic

Other listed brands

Acflox Acflox 400 mgW. Woodward Pakistan (Pvt) Ltd. · PKR 988.30 Admox 400 mgPharma Lord (Pvt) Ltd · PKR 801.91 Ajimox 400 mgCunningham Pharmaceuticals (Pvt.) Ltd. · PKR 810.39 Aramox 400 mgARP (PVT) Limited · PKR 786.82 ARBIMOX 400 MGPlatinum Pharmaceuticals · PKR 994.59 Aspimox 400 mgAspin Pharma · PKR 762.72 Astromox 400 mgCSH Pharmaceuticals (Pvt.) Ltd., · PKR 922.13 Astron 400 mgEpharm Laboratories · PKR 873.67

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 101028

MedInfoBase. (2026). Moxilab 0.5% Ophthalmic drops (3ml), Medimarker's Laboratories — registration and price record [Data set]. MedInfoBase. Retrieved October 9, 2026, from https://medinfobase.com/brand/moxilab-0-5-101028-3ml-medimarkers-laboratories-13405/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 101028.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.